EKF DIAGNOST.HLDGS.LS-,01EKF DIAGNOST.HLDGS.LS-,01EKF DIAGNOST.HLDGS.LS-,01

EKF DIAGNOST.HLDGS.LS-,01

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
0.01EUR
Revenue estimate
‪30.32 M‬EUR
Market capitalization
‪146.61 M‬EUR
‪2.71 M‬EUR
‪60.68 M‬EUR
‪432.12 M‬
Beta (1Y)
−0.47

About EKF DIAGNOST.HLDGS.LS-,01

Headquarters
Penarth
Employees (FY)
317
Founded
1990
ISIN
GB0031509804
FIGI
BBG000QWK8C7
EKF Diagnostics Holdings Plc is a vitro diagnostics company, which engages in the designs and manufactures diagnostic equipment for use within point-of-care settings. It operates through the following geographical segments: Germany, USA, Russia, and the United Kingdom. The company was founded in 1990 and is headquartered in Penarth, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange EKF DIAGNOST.HLDGS.LS-,01 stocks are traded under the ticker LYF.
EKF DIAGNOST.HLDGS.LS-,01 is going to release the next earnings report on Sep 10, 2024. Keep track of upcoming events with our Earnings Calendar.
LYF earnings for the last quarter are 0.00 EUR per share, whereas the estimation was 0.01 EUR resulting in a −112.90% surprise. The estimated earnings for the next quarter are 0.01 EUR per share. See more details about EKF DIAGNOST.HLDGS.LS-,01 earnings.
EKF DIAGNOST.HLDGS.LS-,01 revenue for the last quarter amounts to ‪31.30 M‬ EUR despite the estimated figure of ‪30.61 M‬ EUR. In the next quarter revenue is expected to reach ‪30.28 M‬ EUR.
Yes, you can track EKF DIAGNOST.HLDGS.LS-,01 financials in yearly and quarterly reports right on TradingView.
LYF net income for the last quarter is ‪3.13 M‬ EUR, while the quarter before that showed ‪−416.61 K‬ EUR of net income which accounts for 850.25% change. Track more EKF DIAGNOST.HLDGS.LS-,01 financial stats to get the full picture.
Yes, LYF dividends are paid annually. The last dividend per share was 0.01 EUR. As of today, Dividend Yield (TTM)% is 4.32%. Tracking EKF DIAGNOST.HLDGS.LS-,01 dividends might help you take more informed decisions.
Like other stocks, LYF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EKF DIAGNOST.HLDGS.LS-,01 stock right from TradingView charts — choose your broker and connect to your account.
LYF reached its all-time high on Oct 25, 2021 with the price of 1.000 EUR, and its all-time low was 0.266 EUR and was reached on Sep 12, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 317.00 employees. See our rating of the largest employees — is EKF DIAGNOST.HLDGS.LS-,01 on this list?
We've gathered analysts' opinions on EKF DIAGNOST.HLDGS.LS-,01 future price: according to them, LYF price has a max estimate of 0.42 EUR and a min estimate of 0.34 EUR. Read a more detailed EKF DIAGNOST.HLDGS.LS-,01 forecast: see what analysts think of EKF DIAGNOST.HLDGS.LS-,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EKF DIAGNOST.HLDGS.LS-,01 EBITDA is ‪11.80 M‬ EUR, and current EBITDA margin is 19.43%. See more stats in EKF DIAGNOST.HLDGS.LS-,01 financial statements.